About us

We are committed to bring an affordable variant of gene therapy for rare diseases to market. We have the knowledge and expertise in-house for achieving that and our business model is not focused on shareholder value and making excess profit. The first gene therapies for rare diseases have recently come to the market. But they are very expensive: the manufacturers charge millions of euros per patient.

About us

Csm BCC NL 11 Juli 2024 Dirk Van Asseldonk Da0450d1d3

Dirk van Asseldonk

Dirk van Asseldonk is a committed entrepreneur with a strong will to solve the social problem of the excessive prices of advanced therapies for the treatment of rare diseases. Since September 2023, he has been the director of LentiCure.

Pimpijnappel DSCF5999

Pim Pijnappel

Prof. dr. Pim Pijnappel is a leading scientist specializing in stem cells and genetic techniques. After obtaining his Master's degree in Medical Biology and his PhD at Utrecht University, he did postdoctoral research at the EMBL in Heidelberg and the Max Planck Institute in Dresden.

Bodil Willumsen Photo 1 1024X1024

Bodil Willumsen

Bodil Willumsen, Ph.D., is an expert in gene therapy manufacturing and works as a CMC consultant in the field of cell and gene therapy. She has led the CMC team at LentiCure since October 2023.

Isabel Gordaliza Alaguero Wetenschappelijk Onderzoeker Ee963

Isabel Gordaliza-Alaguero

Dr. Isabel Gordaliza-Alaguero is a biomedical scientist and Regulatory Affairs professional with a strong motivation to translate laboratory innovations into practical solutions that improve patients’ lives. Since March 2025, she has been Head of Regulatory Affairs at LentiCure.

Centrum Voor Lysosomale En Metabole Ziekten 0422 001

Center for Lysosomal and Metabolic Diseases

The Center for Lysosomal and Metabolic Diseases is an internationally recognized center of expertise for metabolic diseases and stands for innovation. Clinicians and basic scientists work together to develop and apply new treatments and high-quality diagnostics.

Groep1 Cropped

LentiCure International Scientific Advisory Board

-

Laatste nieuws

Living with Pompe disease: what do patients report?

Tuesday, July 14, 2026

What does Pompe disease really mean for patients' daily lives? The 2024 Pompe Survey Report offers a unique perspective.

Letstalkbusiness (1)

Podcast: Research is the key – Let’s Talk Business

Tuesday, July 14, 2026

The Prinses Beatrix Spierfonds funds, guides, and stimulates scientific research into muscle diseases, because it knows that scientific research is the only key to making all muscle diseases treatable in the future. Listen to the New Business Radio podcast Let’s Talk Business #634.

Kathinka Header Gespiegeld

Donate to the Spierfonds and make a difference

Tuesday, July 14, 2026

Every day, people with a muscle disease need our help. With your donation, you help make groundbreaking research possible, improve treatments, and give hope to thousands of people in the Netherlands. Discover why your contribution can have such an impact.